TCRX Tscan Therapeutics Inc
Company Analysis
Latest News
🔴 Tscan Therapeutics is trading 6% down; no clear catalyst identified
Tscan Therapeutics is trading 5.87% down at $0.30 on October 5, 2026, and the reason for the decline remains unclear. - No new company announcement was listed...
🟢 Tscan Therapeutics is trading 5% up today with broader-market gains a possible contributor
Tscan Therapeutics is trading at $0.33, up +5.45%, with broader-market strength a possible contributor, though the connection is unconfirmed. - No new...
🔴 Tscan Therapeutics is trading 5% down — no clear catalyst identified
Tscan Therapeutics is trading 5.41% lower at $0.32, with no clear company-specific announcement for September 29 explaining the move. - The company’s latest...
🔴 Tscan Therapeutics is trading 5.4% down today
Tscan Therapeutics is trading at $0.33, down 5.39%, with no new company-specific catalyst identified for September 25, 2026. - The latest major company update...
🔴 Tscan Therapeutics is trading 5.27% down today as biotech ETF XBI falls
Tscan Therapeutics is trading 5.27% down now at $0.34, with the decline appearing mainly sector-driven. - No new company-specific announcement or filing was...
🔴 Tscan Therapeutics is trading 8.68% down in pre-market
Tscan Therapeutics is trading at $0.32, down 8.68% in pre-market, with no clear catalyst identified. - No fresh company-specific announcement or filing dated...
🟢 Tscan Therapeutics is trading 5% up today amid a biotech risk-on rotation
Tscan Therapeutics is trading at $0.35, up +5.05%, primarily as part of a broader biotech risk-on rotation. - No fresh company-specific announcement or filing...
🟢 Tscan Therapeutics is trading 6.86% up today as falling oil prices ease inflation concerns
Tscan Therapeutics is trading 6.86% up now at $0.33 after opening amid a broad risk-on rebound. - U.S. equities are gaining as falling oil prices ease...
🟢 Tscan Therapeutics is trading 7% up in pre-market with broader risk-on sentiment
Tscan Therapeutics is trading at $0.33, up +7.02%, with broader pre-market risk-on sentiment the most likely explanation for the move. - Major U.S. indices...
🟢 Tscan Therapeutics is trading 6.6% up in after-hours trading with no clear catalyst identified
Tscan Therapeutics is trading 6.6% up at $0.33, with no clear company-specific announcement or late-breaking catalyst identified. - Shares closed at $0.31 on...
🔴 Tscan Therapeutics is trading 5.6% down today — immediate catalyst unclear
Tscan Therapeutics is trading 5.6% down now at $0.32, with no new company-specific announcement identified for September 18, 2026. - The latest major update...
🟢 Tscan Therapeutics is trading 7.95% up today in pre-market with no company-specific catalyst identified
Tscan Therapeutics is trading 7.95% up now at $0.36 after no new company-specific announcement was identified for September 18, 2026. - The move appears tied...
🟢 Tscan Therapeutics is trading 6.47% up today amid biotech rally and improved risk appetite
Tscan Therapeutics is trading 6.47% up at $0.35 as biotechnology and broader markets rally. - No new company-specific announcement was identified for...
🟢 Tscan Therapeutics is trading 5% up today amid broader risk-on sentiment
Tscan Therapeutics is trading 5.17% up at $0.34, continuing its rebound after reaching $0.31 on September 14. - The stock is recovering from the September 8...
🟢 Tscan Therapeutics is trading 6% up in pre-market with no fresh catalyst identified
Tscan Therapeutics is trading at $0.34, up 5.82%, with no new company-specific catalyst identified. - No new Tscan Therapeutics announcement was identified...
🔴 Tscan Therapeutics is trading 6.63% down in after-hours trading amid broader risk-off conditions
Tscan Therapeutics is trading 6.63% down at $0.30 in after-hours trading, amid broader risk-off market conditions. - It closed at $0.32 on September 15,...
🟢 Tscan Therapeutics is trading 5% up today — immediate catalyst remains unclear
Tscan Therapeutics is trading 5.13% up at $0.32, with no clearly reported company-specific announcement on September 15, 2026. - Latest notable developments...
🔴 Tscan Therapeutics is trading 5.1% down today amid market weakness after hotter producer inflation
Tscan Therapeutics is trading 5.1% down at $0.31 amid broad market weakness after hotter-than-expected August producer inflation increased concerns about...
🟢 Tscan Therapeutics is trading 7.5% up in pre-market
Tscan Therapeutics is trading 7.5% up at $0.35 in pre-market, with no clear catalyst identified. - No major company-specific announcement dated September 10,...
🟢 Tscan Therapeutics is trading 5.86% up in after-hours trading after rebounding from heavy selling tied to reorganization
Tscan Therapeutics is trading 5.86% up at $0.36 in after-hours trading after rebounding from heavy recent selling tied to its reorganization. - It closed at...